~~<i id='BDE3022632'><strike id='BDE3022632'><tt id='BDE3022632'><pre id='BDE3022632'></pre></tt></strike></i>~~

Home» Wikipedia» leisure time

leisure time

author：hotspot 2025-09-10 08:37:34 Page View：233

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals
Next article： Peter Hotez and the public health issue of online harassment

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Illustration:AlexHogan/STAT;Photo:EisaiviaAPWanttostayontopofthescienceandpoliticsdrivingbiotechtoda

What does generative AI mean for health care? We asked experts

MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

Lilly’s weekly insulin works as well as daily products, new studies show

AdobeEliLillyreportedThursdaythatitsexperimentalweeklyinsulinworkedaswellasdailybasalinsulinproducts